Contact

Category: Administration

Administration represents the clinical posology, delivery vectors, and pharmacokinetics of administering macrocyclic lactone anthelmintics to domestic animals, ensuring accurate weight-titrated dosing and preventing systemic toxicity.

Foundational Pillars
Pharmacological Framework
Clinical Directory
Frequently Asked Questions

Foundational Clinical Pillars

Core Reference

The Longevity of Ivermectin: A Detailed Chronicle of Clinical Use Across Five Decades

Evaluates pharmacological classification, distinguishing avermectin derivatives from hormonal or steroid pathways.

Clinical Benchmark

How Long Has Ivermectin Been Around? A 50-Year History from 1974 to the Present

Clinical parameters and syringe calibration standards for administering calibrated anthelmintic paste formulations.

Safety Standard

Where Did Ivermectin Come From? The Discovery of Streptomyces avermitilis and Satoshi Ōmura

Broad-spectrum pharmacological profile, receptor binding affinities, and therapeutic index analysis.

Pharmacokinetics, Delivery Formulations & Administration Kinetics

The safe therapeutic administration of ivermectin requires precise differentiation between prophylactic and microfilaricidal dosing. In canine preventive medicine, heartworm prophylaxis relies on microgram concentrations (approximately 6 to 12 mcg/kg orally every 30 days). Conversely, dermatological indications—such as generalized demodicosis or sarcoptic acariasis—demand daily dosages between 300 and 600 mcg/kg, creating a fifty-fold exposure differential that requires strict veterinary supervision.

Ivermectin exhibits pronounced lipophilicity, leading to extensive tissue distribution and prolonged elimination half-lives across mammalian species. In dogs, hepatic clearance via cytochrome P450 enzymes and fecal biliary excretion account for more than ninety percent of parent drug elimination. Oral bioavailability varies substantially between liquid suspensions, soft chewable substrates, and tablet matrices, necessitating vehicle-specific dosing considerations.

Administration ModalityBioavailability & KineticsPrimary Clinical Application
Oral Chewable / TabletRapid gastrointestinal absorption; 80% bioavailabilityHeartworm prophylaxis (6 mcg/kg) & intestinal nematodes
Topical Pour-On / Spot-OnTransdermal absorption; steady systemic plasma plateauEctoparasitic infestations, mange, and ear mites
Injectable (Subcutaneous)Extended depot release; prolonged elimination half-lifeLivestock herd management and severe refractory acariasis
Topical Lotion / Cream (1%)Localized dermal accumulation; minimal systemic fluxFacial demodicosis, blepharitis, and cutaneous acarids

Administering oral antiparasitics with a high-lipid meal enhances intestinal absorption and systemic bioavailability. However, in animals carrying the ABCB1 (formerly MDR1) deletion allele, elevated systemic absorption significantly increases neurotoxic susceptibility, mandating genetic verification prior to introducing high-concentration therapeutic regimens.

Topic Directory & Methodologies

Formulations, Pastes & Oral Solutions

Dosing Titration & Toxicological Verification

Advanced Formulations & Protocols

Frequently Asked Clinical Questions

How is ivermectin administered for canine heartworm prevention?

Canine heartworm prevention is administered orally once every 30 days at a microgram dosage of 6 to 12 mcg/kg of body weight, usually formulated in veterinary chewable tablets to target microfilariae before tissue maturation.

Why must ivermectin paste not be dosed arbitrarily by pet owners?

Equine or livestock ivermectin pastes are highly concentrated (typically 1.87% or 18.7 mg/g). Attempting to divide a syringe designed for an 1,100-pound horse for a 20-pound dog results in fatal overdose and profound neurological toxicosis.

Does food intake alter ivermectin absorption in dogs?

Yes. Co-administration with food, particularly dietary lipids, enhances oral bioavailability and gastrointestinal uptake. For consistent pharmacokinetic exposure, preventive medications should be given consistently according to package guidelines.

Notice & Clinical Safe Harbor: This educational reference is maintained by the Veterinary Parasitology & Pharmacology Standards Desk for academic, informational, and clinical research purposes. Data models published veterinary pharmacology literature, statutory veterinary monographs, and established anthelmintic posology standards. This portal does not provide certified individual veterinary medical diagnosis, prescription services, or personalized treatment regimens. For clinical diagnoses, suspected parasitic toxicosis, and individualized dosing protocols, always consult an actively licensed veterinary practitioner in your jurisdiction.

AI Editorial Policy